LIGAND PHARMACEUTICALS (LGND) Stock Balance Sheet
NASDAQ:LGND • US53220K5048
Current stock price
221.79 USD
-3.3 (-1.47%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 174.93M | 256.17M | 22.95M | 45.00M | 19.50M | |||
| Marketable Securities | 558.59M | 183.86M | 147.35M | 166.90M | 321.60M | |||
| Receivables | 61.05M | 42.45M | 39.31M | 35.00M | 91.60M | |||
| Inventories | 9.13M | 14.11M | 23.97M | 13.30M | 27.30M | |||
| Other Current Assets | 28.58M | 18.83M | 3.84M | 3.40M | 4.70M | |||
| Total Current Assets | 832.27M | 331.56M | 237.43M | 263.60M | 464.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.79M | 24.81M | 25.06M | 27.50M | 53.30M | |||
| Investments And Advances | 167.95M | 10.91M | 48.32M | N/A | N/A | |||
| Goodwill | 101.54M | 105.25M | 103.37M | 105.70M | 181.20M | |||
| Intangibles | 422.31M | 451.67M | 366.90M | 352.60M | 561.20M | |||
| Other Non-Current Assets | 25.77M | 17.58M | 6.14M | 13.30M | 37.20M | |||
| Total Non-Current Assets | 728.37M | 610.22M | 549.79M | 499.10M | 832.80M | |||
| TOTAL ASSETS | 1.56B | 941.77M | 787.22M | 762.70M | 1.30B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 24.00K | 24.00K | 7.00K | 76.70M | 0.00 | |||
| Accrued Expenses | 31.93M | 28.55M | 12.25M | 16.40M | 19.60M | |||
| Accounts Payable | 3.24M | 38.37M | 2.43M | 5.30M | 8.40M | |||
| Other Current Liabilities | 2.26M | 3.30M | 2.10M | 400.00K | 13.60M | |||
| Total Current Liabilities | 37.45M | 37.11M | 16.78M | 98.80M | 41.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 446.19M | 0.00 | 0.00 | 0.00 | 320.70M | |||
| Deferred Taxes/Income | 52.61M | 46.68M | 31.62M | 30.60M | 59.10M | |||
| Other Non-Current Liabilities | 7.18M | 27.54M | 37.90M | 35.80M | 55.00M | |||
| Total Non-Current Liabilities | 505.98M | 74.22M | 69.52M | 66.40M | 434.70M | |||
| TOTAL LIABILITIES | 543.42M | 111.33M | 86.30M | 165.20M | 476.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 608.09M | 498.98M | 503.02M | 450.90M | 449.10M | |||
| Additional Paid In Capital | 400.65M | 337.38M | 198.70M | 147.60M | 373.00M | |||
| Common Shares | 20.00K | 20.00K | 18.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 8.46M | -5.94M | -817.00K | -1.00M | -900.00K | |||
| Shares Outstanding | 19.77M | 19.11M | 17.56M | 17.00M | 16.80M | |||
| Tangible Book Value per Share | 24.95 | 14.32 | 13.14 | 8.19 | 4.69 | |||
| Total Shareholders' Equity | 1.02B | 830.44M | 700.91M | 597.50M | 821.20M | |||
| TOTAL LIABILITIES AND EQUITY | 1.56B | 941.77M | 787.22M | 762.70M | 1.30B | |||
| Statistics | ||||||||
| Debt/Equity | 0.44 | N/A | N/A | N/A | 0.39 | |||
| Current Ratio | 22.23 | 8.93 | 14.15 | 2.67 | 11.15 | |||
| Return On Assets (ROA) | 7.97% | -0.43% | 6.63% | -4.38% | 4.40% | |||
| Return On Equity (ROE) | 12.23% | -0.49% | 7.44% | -5.59% | 6.95% | |||
| Return On Invested Capital (ROIC) | 2.45% | 2.01% | 1.01% | 0.36% | 4.96% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 4.72% | 3.91% | 1.29% | 0.52% | 6.81% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 14.03% | N/A | 5.97% | N/A | 36.15% | |||
All data in USD , ROIC based on taxRate of 0.21